Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. Case and Commentary Apr 2016 Prenatal Risk Assessment and Diagnosis of Down Syndrome: Strategies for Communicating Well with Patients Eva Schwartz, MD and Kishore Vellody, MD Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision. AMA J Ethics. 2016;18(4):359-364. doi: 10.1001/journalofethics.2016.18.4.ecas1-1604. State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604. Podcast Nov 2022 Ethics Talk Series on US Abortion Care After Dobbs, Episode 3/5: How Do We Teach Evidence-Based Standard of Care Now? Dr Jody Steinauer joins Ethics Talk to discuss possible responses to what the Dobbs decision demands of clinician-teachers. Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503. State of the Art and Science Apr 2005 Complications of Anticoagulation with Heparin Mahesh Krishnamurthy, MD and Michael L. Freedman, MD Virtual Mentor. 2005;7(4):297-300. doi: 10.1001/virtualmentor.2005.7.4.cprl1-0504. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Viewpoint Jan 2006 Is Prenatal Genetic Screening Unjustly Discriminatory? Jeff McMahan, PhD Virtual Mentor. 2006;8(1):50-52. doi: 10.1001/virtualmentor.2006.8.1.oped1-0601. Viewpoint Jan 2006 The Uncertain Rationale for Prenatal Disability Screening David Wasserman, JD and Adrienne Asch, PhD Virtual Mentor. 2006;8(1):53-56. doi: 10.1001/virtualmentor.2006.8.1.oped2-0601. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105.
Case and Commentary Apr 2016 Prenatal Risk Assessment and Diagnosis of Down Syndrome: Strategies for Communicating Well with Patients Eva Schwartz, MD and Kishore Vellody, MD Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision. AMA J Ethics. 2016;18(4):359-364. doi: 10.1001/journalofethics.2016.18.4.ecas1-1604.
State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.
Podcast Nov 2022 Ethics Talk Series on US Abortion Care After Dobbs, Episode 3/5: How Do We Teach Evidence-Based Standard of Care Now? Dr Jody Steinauer joins Ethics Talk to discuss possible responses to what the Dobbs decision demands of clinician-teachers.
Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503.
State of the Art and Science Apr 2005 Complications of Anticoagulation with Heparin Mahesh Krishnamurthy, MD and Michael L. Freedman, MD Virtual Mentor. 2005;7(4):297-300. doi: 10.1001/virtualmentor.2005.7.4.cprl1-0504.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Viewpoint Jan 2006 Is Prenatal Genetic Screening Unjustly Discriminatory? Jeff McMahan, PhD Virtual Mentor. 2006;8(1):50-52. doi: 10.1001/virtualmentor.2006.8.1.oped1-0601.
Viewpoint Jan 2006 The Uncertain Rationale for Prenatal Disability Screening David Wasserman, JD and Adrienne Asch, PhD Virtual Mentor. 2006;8(1):53-56. doi: 10.1001/virtualmentor.2006.8.1.oped2-0601.